Learning Center Resources
Learning Center Recorded Event

AllType FASTplex v2: Our HLA Laboratory Experience ASHI 2021 Symposium

Having trouble viewing this video? Click here.

Dr. Mostafa’s laboratory wanted to implement next-generation sequencing (NGS) to resolve HLA alleles in transplant patients. They evaluated ~640 HLA alleles with the One Lambda™ AllType™ FASTplex™ v2 NGS Assay, and results obtained were ≥99.8% concordant with those obtained using their usual method. Results obtained with the recommended AllType FASTplex NGS v2 protocol and an alternative protocol AllType FASTplex NGS v2 that omitted DNA purification were 100% concordant, and the laboratory was able to reduce its turnaround time by one full working day.

Share This Page

Speaker:
Ahmed Mostafa, MD, PhD
St. Paul’s Hospital, Saskatoon, Canada

Recorded:
Sep 28, 2021

Series: ASHI 2021 Symposium |  Adapting Laboratory Diagnostics to a Changing Landscape

Videos In This Series

Filling in the gaps: A Single-Center Experience with ExPlex

  1. AllType™ FASTplex™ v2: Our HLA Laboratory Experience ❯
  2. Filling in the gaps: A Single-Center Experience with ExPlex ❯
  3. UNOS Kidney Allocation: The Evolving Landscape ❯
Join our Community
Get important news, updates and more
Sign up
© 2023 Thermo Fisher Scientific Inc. All rights reserved.